Panelists discuss how ciltacabtagene autoleucel (cilta-cel) demonstrates superior outcomes compared to real-world physician’s ...

Accurately diagnosing T-cell lymphoma often takes time. Given that cutaneous T-cell lymphoma shares symptoms with many other benign conditions, it takes an average of 6 years from disease onset to ...

extranodal T-cell lymphoma, cutaneous T-cell lymphomas (Sézary syndrome and Mycosis fungoides), anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma.

We have 3 FDA-approved autologous CAR T-cell therapies for relapsed and refractory large B-cell lymphoma that can be treated. Patients can get those treatments as a third or later line with 3 ...

When your doctor talks to you about your B-cell lymphoma, they'll tell you what type you have. It's an important piece of info to get, because each type of this cancer acts differently and has its ...

Your B-cell lymphoma has gotten smaller, but it's still there. Usually the cancer has shrunk by half or more. Complete remission. Your doctor can't find any sign of your cancer on scans and other ...

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced a collaboration with BeiGene Ltd., a global oncology company that intends to change its name ...

Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live longer and better destroy cancer cells in a mouse model of melanoma compared ...